Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing methylphenidate preference in ADHD patients using a choice procedure.

Emily MacDonald Fredericks1, Scott H Kollins

  • 1Department of Pediatrics, University of Michigan Health System, 1924 Taubman Center, P.O. Box 0318 Ann Arbor, MI, 48109-0318, USA.

Psychopharmacology
|July 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generative Artificial Intelligence Applications Use Among US Youth.

JAMA network open·2026
Same author

Smartphone Engagement During School Hours Among US Youths.

JAMA network open·2025
Same author

Assessment of Attention-Deficit/Hyperactivity Disorder in Young Autistic Children.

Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53·2025
Same author

Effects of initial nicotine exposure on cognition and nicotine reinforcement among non-smoking young adults with and without attention deficit hyperactivity disorder.

Journal of psychopharmacology (Oxford, England)·2025
Same author

Technology Effects and Child Health: Wellness Impact and Social Effects (TECHWISE): Protocol for a Prospective, Observational, Real-World Study.

JMIR research protocols·2025
Same author

A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2024

Adults with ADHD preferred methylphenidate (MPH) over placebo, but this preference appears linked to therapeutic benefits, not abuse potential. MPH choosers showed greater symptom reduction and higher baseline ADHD severity.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Methylphenidate (MPH) is a common treatment for attention deficit hyperactivity disorder (ADHD), known for its clinical benefits.
  • Concerns exist regarding the abuse potential of MPH despite its effectiveness.

Purpose of the Study:

  • To investigate MPH preference in adults with ADHD using a choice procedure.
  • To determine the relationship between drug preference, treatment efficacy, and abuse potential.

Main Methods:

  • Ten adult volunteers (18-22 years) diagnosed with ADHD and on MPH treatment participated.
  • A double-blind choice procedure assessed preference through sampling and choice sessions (MPH vs. placebo/no capsule).

Main Results:

Related Experiment Videos

  • MPH was significantly preferred over placebo (P<0.001).
  • Participants were divided into MPH choosers and non-choosers.
  • MPH reduced ADHD symptoms and stimulant effects in choosers, who also had higher baseline symptom levels.

    • Conclusions:

    • MPH preference in this ADHD sample correlates with therapeutic efficacy, not necessarily abuse potential.
    • MPH choosers exhibited more severe ADHD symptoms than non-choosers.
    • Further research is needed to explore MPH choice in diverse populations and its relation to clinical efficacy.